A recent decision aims to reduce costs for patients. The move could lead to significant savings, potentially up to Rs 2,500 crore annually. This change follows concerns raised about large price differences for certain medicines.

A cap has been announced for trade margins on certain drugs. The new measure applies to a range of medicines, including branded and generic versions.

Further details about the decision and its impact are available from the source, including the number of medicines affected and the potential reduction in maximum retail price.